Cirrhosis of the Liver
What Is Cirrhosis?
Cirrhosis is a chronic, progressive liver disease in which normal liver tissue is gradually replaced by scar tissue, leading to permanent structural damage and impaired liver function.
It represents the final stage of long-standing liver injury caused by conditions such as fatty liver disease (MASLD/NASH), chronic alcohol use, viral hepatitis, and autoimmune or metabolic liver disorders.
Once cirrhosis develops, the liver cannot fully return to normal, but disease progression and complications can often be controlled with timely medical care.
Why Cirrhosis Matters Clinically
Cirrhosis is clinically significant not because of the label, but because of the complications it leads to.
As scarring progresses, blood flow through the liver becomes obstructed, resulting in portal hypertension, reduced detoxification, impaired protein synthesis, and immune dysfunction.
Without appropriate monitoring and treatment, cirrhosis can lead to ascites, variceal bleeding, infections, hepatic encephalopathy, kidney failure, and liver cancer — all of which directly impact survival and quality of life.
Early vs Advanced Cirrhosis: What Changes?
Early (Compensated) Cirrhosis
Often asymptomatic or minimally symptomatic
Liver function tests may be near normal
Patients may feel entirely well
Complications are absent
Disease progression can often be slowed or stabilised
Advanced (Decompensated) Cirrhosis
Development of ascites, jaundice, bleeding, or confusion
Frequent hospitalisations
Declining nutritional and muscle status
Increased infection risk
Liver transplant assessment may become necessary
Key clinical reality:
Cirrhosis does not suddenly become severe — deterioration usually follows missed early warning signs.
Common Mistakes Patients Make
Waiting for symptoms before seeking care
Assuming “normal” liver enzymes mean the liver is healthy
Believing ultrasound alone can rule out serious liver disease
Using herbal or alternative supplements without medical guidance
Attempting rapid weight loss or alcohol cessation without supervision
Delaying specialist review because reports appear “stable”
These delays often convert a manageable condition into a high-risk one.
When Specialist Input Changes Outcomes
Specialist hepatology care significantly alters outcomes in cirrhosis when:
Ascites appears for the first time
There is any episode of confusion or altered sleep pattern
Gastrointestinal bleeding occurs
Recurrent infections develop
FibroScan, imaging, or labs show discordant results
MELD or Child–Pugh scores begin to rise
Early specialist involvement allows proactive complication prevention rather than reactive hospital care.
When Is Liver Transplant Considered?
Liver transplantation is considered based on functional liver failure, not simply the diagnosis of cirrhosis.
Transplant evaluation is appropriate when:
Decompensation occurs
Medical therapy no longer controls complications
Quality of life declines despite optimal care
Survival benefit from transplant exceeds risk
Important clarification:
Not every patient with cirrhosis needs a transplant — but delayed referral can remove transplant as an option.
Correct timing, not panic, determines outcomes.
Frequently Asked Questions About Cirrhosis
Can cirrhosis be reversed?
Advanced scarring cannot be reversed, but disease progression and complications can often be controlled.
Is cirrhosis life-threatening?
It can be, especially when complications develop, which is why regular monitoring is essential.
Do all cirrhosis patients need a transplant?
No. Many patients live stable lives with medical management and surveillance.
Can I live a normal life with cirrhosis?
Yes, particularly in early stages, with lifestyle modification and structured care.
Which tests matter most in cirrhosis?
FibroScan, imaging, platelet count, bilirubin, INR, and albumin are more informative than enzymes alone.
When should I see a hepatologist?
At diagnosis, at the first complication, or when test results show progression — not after repeated hospitalisations.
Clinical Perspective
From a hepatologist’s perspective, cirrhosis is not a single event but a dynamic disease process. Outcomes depend less on the diagnosis itself and more on timing, surveillance, nutrition, and complication management. Early engagement allows control; delayed care often forces crisis decisions.
Dr Kalal offers opd AND inpatient (IPD) hepatology care, transplant work-up coordination, and long-term post-transplant follow-up, including immunosuppression optimization, infection prevention, metabolic risk control, and graft surveillance.
Virtual consultations are available for patients and families in the US, UK, UAE, Europe, Singapore, Australia, New Zealand, Canada, and the Middle East, with continuity of care coordinated alongside local treating teams.
He is the first DM (Hepatology) specialist from Maharashtra, and is currently Associate Director – Hepatology & Liver Transplantation at Gleneagles Hospital, Mumbai.
Appointments & Clinical Enquiries:
👉 drchetankalal.com
This service is intended for patients seeking clarity, risk assessment, and evidence-based clinical direction in liver disease and transplant care.